Earnings History Data for CinCor Pharma (CINC) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

CinCor Pharma

CinCor Pharma Inc. is a clinical-stage biopharmaceutical company. It focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. CinCor Pharma Inc. is based in BOSTON.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
03-11-2022	PM		CINC	CinCor Pharma	1,271	-0.51	-0.59	0.00	CinCor Pharma GAAP EPS of -$0.51 beats by $0.06 [11/3/2022 9:21 AM]	28.12	-4.82 (-14.63%)	32.94	0.0 (0.00%)	13.00 - 43.15	906,598	320,000	74,531
CinCor Pharma GAAP EPS of -$0.51 beats by $0.06 [11/3/2022 9:21 AM] CinCor Reports Third Quarter Financial Results and Provides Corporate Update [Nov-03-22 08:00AM]
08-08-2022	PM	8:00 AM ET (Aug 8)	CINC	CinCor Pharma	859.00	-0.56	-0.50	0.00	CinCor Pharma GAAP EPS of -$0.56 misses by $0.08 [8/8/2022 8:46 AM]	34.92	11.47 (48.91%)	31.99	8.54 (36.42%)	13.00 - 43.15	2,662,669	120,000	50,136
CinCor adds 13% as mid-stage trial for antihypertensive agent reaches main goal [8/8/2022 8:18 AM] CinCor Pharma GAAP EPS of -$0.56 misses by $0.08 [8/8/2022 8:46 AM] CinCor Reports Second Quarter Financial Results and Provides Corporate Update [Aug-08-22 07:15AM] CinCor Pharma Announces Positive Topline Data for Phase 2 BrigHtn Trial Evaluating Baxdrostat, its Selective Aldosterone Synthase Inhibitor, in Treatment-Resistant Hypertension [Aug-08-22 07:00AM]
10-05-2022	PM		CINC	CinCor Pharma, Inc.	819.00	-0.50	-0.50	0.00	CinCor Pharma GAAP EPS of -$0.50 [5/10/2022 8:57 AM]	21.95	0.92 (4.37%)	0.0	0.0 (0.00%)	13.01 - 30.66	27,254	165,890	0
CinCor Pharma GAAP EPS of -$0.50 [5/10/2022 8:57 AM] CinCor Reports First Quarter Financial Results and Provides Corporate Update [May-10-22 08:00AM]
22-03-2022	PM	Before the open (Mar 22)	CINC	CinCor Pharma, Inc.	722.35	-15.71	-1.56	0.00	CinCor Pharma GAAP EPS of -$15.71 [3/22/2022 10:21 AM]	15.92	1.10 (7.42%)	15.50	0.68 (4.59%)	13.01 - 30.66	181,868	295,918	1,267
CinCor Pharma GAAP EPS of -$15.71 [3/22/2022 10:21 AM] CinCor Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update [Mar-22-22 08:19AM]